Seoul Pharma Co., Ltd. (018680) - Financials, balance sheet (annual)

3,460 KRW

0.43%

Last update Jun 5, 3:00 PM KST

Market closed

Day range

3,460

3,440

3,500

Previous close

3,475

Open

3,475

Access this stock data via API

Seoul Pharma Co., Ltd.

3,460.00

0.43%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	71.6B	63.3B	62.4B	62.3B
Current assets	32.3B	25.6B	26.0B	24.8B
Cash	—	1.3M	—	—
Cash equivalents	7.5B	6.6B	11.7B	13.8B
Cash and cash equivalents	7.5B	6.6B	11.7B	13.8B
Other short term investments	—	3.1B	—	—
Accounts receivable	9.1B	5.0B	4.9B	4.4B
Other receivables	404.7M	95.5M	71.5M	33.2M
Inventory	12.1B	10.7B	9.2B	6.5B
Prepaid assets	3.1B	111.1M	79.3M	45.8M
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	1.4M	1.6M	10.0M	11.0M
Non current assets	39.4B	37.7B	36.4B	37.4B
Properties	3.6B	910.4M	901.4M	1.3B
Land and improvements	5.2B	5.2B	5.2B	5.2B
Machinery furniture equipment	25.4B	25.7B	24.5B	23.2B
Construction in progress	—	40.5M	132.9M	390.9M
Leases	—	—	—	—
Accumulated depreciation	-28.6B	-28.0B	-27.4B	-23.3B
Goodwill	809.4M	841.7M	881.3M	865.1M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	809.4M	841.7M	881.3M	865.1M
Investments and advances	—	—	—	—
Other non current assets	20	100	3.9M	4.1M
Total liabilities	31.4B	24.7B	27.0B	43.3B
Current liabilities	14.1B	20.5B	13.9B	28.8B
Accounts payable	2.4B	2.8B	3.0B	2.0B
Accrued expenses	—	—	—	—
Short term debt	3.7B	10.5B	4.5B	18.5B
Deferred revenue	—	—	—	—
Tax payable	155.9M	—	—	—
Pensions	—	—	—	—
Other current liabilities	1.6B	1.4B	1.4B	1.4B
Non current liabilities	17.3B	4.2B	13.1B	14.5B
Long term provisions	863.0M	423.4M	—	—
Long term debt	12.5B	470.7M	10.5B	10.9B
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	269.3M	232.3M	216.9M	220.5M
Shareholders equity
Common stock	5.8B	5.8B	5.8B	4.3B
Retained earnings	4.8B	3.1B	-19.4B	-20.7B
Other shareholders equity	—	—	—	—
Total shareholders equity	40.2B	38.6B	35.4B	19.0B
Additional paid in capital	29.6B	29.6B	49.0B	35.4B
Treasury stock	—	—	—	—
Minority interest	—	—	—	—